VCM
MRVI icon

Voleon Capital Management’s Maravai LifeSciences MRVI Stock Holding History

Voleon Capital Management’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$466K Buy
+74,649
New +$322K 0.01% 601
2025
Q2 		– Sell
-134,089
Closed -$296K – 510
2025
Q1 		$296K Buy
+134,089
New +$530K 0.02% 293

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.91B AUM 14.64% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
1WCM
12 West Capital Management New York $535M AUM 25.99% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OAM
Ophir Asset Management Sydney, Australia $1.22B AUM 100.03% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

Voleon Capital Management's MRVI Position: Q2 2026 in Review

Voleon Capital Management opened a new position in Maravai LifeSciences (MRVI) in Q2 2026: 74,649 shares worth $466K. The stake represents 0.01% of the portfolio and ranks #601 among its holdings. This is a return to the name: Voleon Capital Management previously reported a position in MRVI as recently as Q1 2025.

Voleon Capital Management first reported a position in MRVI in Q1 2025 and has held it in 2 quarters since. 177 funds tracked by Wall St. Rank hold MRVI as of Q2 2026.

  • Voleon Capital Management held 74,649 shares of Maravai LifeSciences worth $466K as of Q2 2026.
  • Maravai LifeSciences was a new Voleon Capital Management position in Q2 2026.
  • Maravai LifeSciences made up 0.01% of Voleon Capital Management's portfolio in Q2 2026, its #601 holding.
  • Voleon Capital Management first reported a position in Maravai LifeSciences in Q1 2025 and has held it in 2 quarters since.
  • 177 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q2 2026.

Based on Voleon Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.